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Introduction 
 Companion animals, as humans, have an incredibly 
large and diverse microbiota. The purpose of this work 
is to summarize some important characteristics of S. 
pseudintermedius, an important member of this 
microbiota. 
 S. pseudintermedius is a both skin and mucous 
membrane commensal in dogs and cats, causing 
opportunistic infections in both animals. 
 Is a Gram-positive non sporulated cocci that appears 
as clusters upon microscopical examination. 
Conclusions 
Emergence of MRSP 
 This microorganism was initially called Staphylococcus intermedius when it was discovered by Hajek 
in 1976, but after the development of molecular typing techniques it has been differentiated in 3 
closely related species referred together to as the Staphylococcus Intermedius Group (SIG):  
 S. intermedius  S. pseudintermedius  S. delphini 
Gortel K. Vet Clin North Am Small Anim Pract , 2013  
 S. pseudintermedius is the most prevalent Coagulase Positive Staphylococci inhabitant of 
cats and dogs, and the carriage rates ranges between: 
5 – 45% 
46 – 92 % 
 Under certain conditions S. pseudintermedius may cause some diseases. 
Pyoderma 
 It’s a type of dermatitis mainly caused by S. pseudintermedius, and a common problem in clinical practice. 
 It’s classified as primary or secondary (depending on whether an underlying or associated disease is identified) and 
depending on the depth of the infection: 
 
 Surface pyodermas or pseudopyodermas  Superficial pyodermas   Deep pyodermas 
 Staphylococcus pseudintermedius is an important 
pathogen of companion animals like dogs and cats. 
 Knowledge of sites of colonization is important to 
detect carriers and prevent underestimation on its 
prevalence. 
 There has been a sudden emergence of MRSP in dogs and cats and it 
constitutes a prominent risk to animal health. 
 Human infections have been reported several times, even without 
exposure to animals, so clinicians should be aware of the potential risk that it 
can be to human health. 
 Transmission and resistance control is necessary to reduce the 
emergence of multi-resistant clones and to prevent zoonotic 
infections. 
 Identification of more virulence factors will provide new tactics to 
prevent and treat infections caused by S. pseudintermedius. 
Gortel K. Vet Clin North Am Small Anim Pract , 2013  Balazs V. REDVET, 2012 
Sites of colonization 
 Combined sampling results in 
detection of 99% of carriers. 
http://www.petclic.es/sites/default/files/library/dalmata_-_razas_de_perros.jpg 
 Since 2006, MRSP has increased and emerged as a significant 
animal health problem in veterinary medicine. 
 Meticillin resistance is mediated by the mecA gene, located 
within a mobile genetic element called SCCmec which can 
contain resistance genes to other antibiotics. 
Gortel K. Vet Clin North Am Small Anim Pract , 2013  
 The depth of the disease will have an impact on its severity and, therefore, in the treatment and prognosis. 
http://biopsy.files.wordpress.com/2008/04/antibiotic-resistance.jpg?w=450&h=382 
 Use of antimicrobials in pet animals has increased 
substantially in most industrialized countries. 
 MRSP clones are not shared between Europe and North 
America, suggesting that the mecA gene has been acquired 
several times by different S. pseudintermedius. 
 Europe  ST71  North America   ST68 
 The treatment of infections with MRSP is a new 
challenge in veterinary medicine because of the very 
limited therapeutic options. 
S. pseudintermedius as a Zoonotic Agent 
 The first case of human infection with S. 
pseudintermedius from a dog bite was described over 20 
years ago.  
 Since then, human infections with this microorganism 
have been reported occasionally, often directly related 
to close contact with a pet dog. 
 S. pseudintermedius can also cause infection in healthy 
individuals even without exposure to animals. 
 Transmission of MRSP via hospital staff, pet owners  
and/or the environment can occur. 
Kelesidis T. Int J Infect Dis, 2010  
 Direct inoculation of this pathogen into 
the skin and soft tissues causes skin 
abscesses. 
Infection and Resistance Control 
 Superficial skin infections caused by S. pseudintermedius can be 
effectively treated with topical antimicrobial agents, preventing 
the exposure of microorganisms to antibiotics and reducing the 
probability of acquiring resistance. 
 Control measures to reduce the risk of transmission of S. 
pseudintermedius. 
In veterinary Hospitals In Households 
Environment Cleaning and 
Disinfection 
Avoid contact with infected sites 
Personal Protective Equipment 
Restrict contact with mucous 
membranes 
Hand Hygiene  Hand hygiene 
Animal Cohorting and Hospital 
Design 
S. pseudintermedius vaccine potential 
 Surface-exposed proteins are 
likely to interact with the host 
immune system. 
 Identification of these proteins 
results in the identification of 
vaccine candidates. 
 The cell-wall-anchored 
proteins SpsD and SpsO can 
mediate bacterial binding to 
canine corneocytes and 
represent potential therapeutic 
targets for the prevention and 
treatment of canine 
staphylococcal pyoderma. 
Clusters of cocci adhering to a corneocyte on skin surface 
cytology 
Lactococcus lactis expressing S. 
pseudintermedius SpsO adhered to canine 
corneocytes 
Bannoehr J. Vet Dermatol, 2012   
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